-
-
Active Ingredient:Metronidazole
-
Content Specification:500mg Metronidazole per 100ml solution
-
Pharmaceutical Form:Sterile intravenous infusion solution
-
Applicable Standard:International pharmacopoeia specification, hospital clinical grade
-
Storage Condition:Sealed storage, protected from light and high temperature
-
Product Features:Precision liquid dosage, broad-spectrum antibacterial effect, stable curative effect, convenient for intravenous infusion, suitable for clinical routine treatment and bulk hospital reserve
-
Package:
Product Description
Product Overview
Metronidazole Injection 500mg/100ml is a classic broad-spectrum nitroimidazole antibiotic widely used in global clinical treatment. It exhibits powerful bactericidal activity against anaerobic bacteria and significant therapeutic effects on various protozoan infections, effectively inhibiting bacterial proliferation and eliminating infection symptoms.
Metronidazole Injection 500mg 100ml: What the Published Guidance Says
A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.
Before Metronidazole Injection 500mg 100ml is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.
- WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe
- Watch group — supplied, but under stewardship Azithromycin, ceftriaxone, ciprofloxacin, clarithromycin, cefuroxime, netilmicin, norfloxacin, ofloxacin, neomycin and kanamycin sit in the Watch group, reserved for a limited number of specific infectious syndromes and monitored for resistance. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
- Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
These points are quoted because they shape how Metronidazole Injection 500mg 100ml is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Metronidazole Injection 500mg 100ml — Supply Parameters
| Therapeutic group | Antibacterials — Antibacterials |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Levofloxacin Lactate Injection 100ml:300mg, Ciprofloxacin Lactate Injection 200mg/100mL, Amoxicillin Powder for Injection 1g, Netilmicin Injection 100mg/2ml, Metronidazole Injection 5mL:25mg, Gentamicin Injection 2mL:80mg, Clindamycin Injection 300mg/2mL, Ceftriaxone Powder for Injection 1g.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Metronidazole Injection 500mg 100ml is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
This page describes Metronidazole Injection 500mg 100ml as a product of the antibacterials classified in the WHO AWaRe framework family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Frequently Asked Questions
How is Metronidazole Injection 500mg 100ml packaged?
Injection presentations are quoted to your pack specification, with the artwork, pack size and labelling language confirmed before manufacture.
What documentation comes with a shipment of Metronidazole Injection 500mg 100ml?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Metronidazole Injection 500mg 100ml support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which of your antibiotics are in the WHO Access group?
Amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole and chloramphenicol are classified in the Access group under the WHO AWaRe classification.
Can you supply sterile injectable antibiotics with endotoxin data?
Yes. Injectable products are supplied with sterility and bacterial endotoxin results included on the batch certificate of analysis, alongside assay and related-substances data.
Related Antibacterials Products
- Levofloxacin Lactate Injection 100ml:300mg — 100mL
- Ciprofloxacin Lactate Injection 200mg/100mL — 200mg/100mL
- Amoxicillin Powder for Injection 1g — 1g
- Netilmicin Injection 100mg/2ml — 100mg/2mL
- Metronidazole Injection 5mL:25mg — 25mg/5mL
- Gentamicin Injection 2mL:80mg — 80mg/2mL
Browse the full Antibacterials range; all Injectables; the complete product catalogue.
Request a Quotation for Metronidazole Injection 500mg 100ml
Send the specification, pack size, quantity and destination market for Metronidazole Injection 500mg 100ml 500mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
